This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yang, H. Articles by Lee, M.-H. Search for Related Content PubMed PubMed Citation Articles by Yang, H. Articles by Lee, M.-H.

DNA Damage–Induced Protein 14-3-3 Inhibits Protein Kinase B/Akt Activation and Suppresses Akt-Activated Cancer

¹ Department of Molecular and Cellular Oncology and ² Breast Cancer Research Program, The University of Texas M.D. Anderson Cancer Center; Programs in ³ Cancer Biology and ⁴ Genes and Development, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas; ⁵ Department of Surgery, Eastern Virginia Medical School, Norfolk, Virginia; and ⁶ Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore, Maryland

Requests for reprints: Mong-Hong Lee, The University of Texas M.D. Anderson Cancer Center, Box 79, 1515 Holcombe Boulevard, Houston, TX 77030. Phone: 713-794-1323; Fax: 713-792-6059; E-mail: mhlee{at}mdanderson.org.

14-3-3 is induced by tumor suppressor protein p53 in response to DNA damage. p53 can directly transactivate the expression of 14-3-3 to cause a G₂ cell cycle arrest when cell DNA is damaged. The expression of 14-3-3 protein is down-regulated in various tumors, but its function has not been fully established. Protein kinase B/Akt, a crucial regulator of oncogenic signal involved in cell survival and proliferation, is deregulated in many types of cancer. Akt activation can enhance p53 degradation, but its role in DNA damage response is not clear. Here, we show that Akt activation is diminished when p53 and 14-3-3 is up-regulated in response to DNA damage. Evidence is provided that 14-3-3 binds and inhibits Akt. In keeping with this concept, Akt-mediated cell survival is inhibited by 14-3-3 . Significantly, we show that 14-3-3 inhibits Akt-mediated cell growth, transformation, and tumorigenesis. Low expression of 14-3-3 in human primary breast cancers correlates with Akt activation. These data provide an insight into Akt regulation and rational cancer gene therapy by identifying 14-3-3 as a molecular regulator of Akt and as a potential anticancer agent for Akt-activated cancers. (Cancer Res 2006; (66)6: 3096-105)

This article has been cited by other articles:

				C. L. Neal, J. Yao, W. Yang, X. Zhou, N. T. Nguyen, J. Lu, C. G. Danes, H. Guo, K.-H. Lan, J. Ensor, et al. 14-3-3{zeta} Overexpression Defines High Risk for Breast Cancer Recurrence and Promotes Cancer Cell Survival Cancer Res., April 15, 2009; 69(8): 3425 - 3432. [Abstract] [Full Text] [PDF]

				I. Plo, C. Laulier, L. Gauthier, F. Lebrun, F. Calvo, and B. S. Lopez AKT1 Inhibits Homologous Recombination by Inducing Cytoplasmic Retention of BRCA1 and RAD51 Cancer Res., November 15, 2008; 68(22): 9404 - 9412. [Abstract] [Full Text] [PDF]

				M. Alvarez, X. Altafaj, S. Aranda, and S. de la Luna DYRK1A Autophosphorylation on Serine Residue 520 Modulates Its Kinase Activity via 14-3-3 Binding Mol. Biol. Cell, April 1, 2007; 18(4): 1167 - 1178. [Abstract] [Full Text] [PDF]